Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000912282-23-000130
Filing Date
2023-06-15
Accepted
2023-06-15 10:42:50
Documents
2
Period of Report
2023-06-13

Document Format Files

Seq Description Document Type Size
1 form3.html 3  
1 form3.xml 3 1406
2 POWER OF ATTORNEY jainpoa.htm EX-24.1 7261
  Complete submission text file 0000912282-23-000130.txt   10322
Mailing Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112 (720) 437-6580
AYTU BIOPHARMA, INC (Issuer) CIK: 0001385818 (see all company filings)

EIN.: 470883144 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AYTU BIOPHARMA, INC. 373 INVERNESS PARKWAY, SUITE 206 ENGLEWOOD CO 80112
Business Address
JAIN ABHINAV (Reporting) CIK: 0001981291 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38247 | Film No.: 231016289